Activated glial cells influence the effects of MPEP-metabotropic glutamate receptor subtype 5 antagonist in neuropathic pain.

被引：0
|
作者：
Osikowicz, M. [1 ]
Mika, J. [1 ]
Przewlocka, B. [1 ]
机构：
[1] PAS, Inst Pharmacol, Dept Pain & Drug Dependence Pharmacol, Krakow, Poland
来源：
BEHAVIOURAL PHARMACOLOGY | 2006年 / 17卷 / 5-6期
关键词：
D O I：
10.1097/00008877-200609000-00084
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
引用
收藏
页码：553 / 553
页数：1
相关论文
共 50 条
  • [31] Evaluation of the effects of a metabotropic glutamate receptor 5-antagonist on electrically induced pain and central sensitization in healthy human volunteers
    Kalliomaki, J.
    Huizar, K.
    Kagedal, M.
    Hagglof, B.
    Schmelz, M.
    EUROPEAN JOURNAL OF PAIN, 2013, 17 (10) : 1465 - 1471
  • [32] The metabotropic glutamate receptor subtype 5 antagonist MPEP and the Na+ channel blocker riluzole show different neuroprotective profiles in reversing behavioral deficits induced by excitotoxic prefrontal cortex lesions
    Risterucci, C
    Coccurello, R
    Banasr, M
    Stutzmann, JM
    Amalric, M
    Nieoullon, A
    NEUROSCIENCE, 2006, 137 (01) : 211 - 220
  • [33] Changes in Cannabinoid Receptor Subtype 1 Activity and Interaction with Metabotropic Glutamate Subtype 5 Receptors in the Periaqueductal Gray-Rostral Ventromedial Medulla Pathway in a Rodent Neuropathic Pain Model
    Palazzo, Enza
    Luongo, Livio
    Bellini, Giulia
    Guida, Francesca
    Marabese, Ida
    Boccella, Serena
    Rossi, Francesca
    Maione, Sabatino
    de Novellis, Vito
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (02) : 148 - 161
  • [34] Antinociceptive effects following intrathecal pretreatment with selective metabotropic glutamate receptor compounds in a rat model of neuropathic pain
    Fisher, K
    Lefebvre, C
    Coderre, TJ
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 73 (02) : 411 - 418
  • [35] Intrathecal Injection of Metabotropic Glutamate Receptor Subtype 3 and 5 Agonist/Antagonist Attenuates Bone Cancer Pain by Inhibition of Spinal Astrocyte Activation in a Mouse Model
    Ren, Bing-xu
    Gu, Xiao-ping
    Zheng, Ya-guo
    Liu, Cheng-long
    Wang, Dan
    Sun, Yu-e
    Ma, Zheng-liang
    ANESTHESIOLOGY, 2012, 116 (01) : 122 - 132
  • [36] Chronic treatment with MPEP, a metabotropic glutamate receptor type 5 antagonist, prevents the development of levodopa-induced dyskinesias in de novo parkinsonian monkeys
    Morin, N.
    Gregoire, L.
    Gomez-Mancilla, B.
    Gasparini, F.
    Di Paolo, T.
    MOVEMENT DISORDERS, 2011, 26 : S282 - S283
  • [37] The metabotropic glutamate 5 receptor antagonist MPEP decreased cocaine self-administration but not cocaine-induced facilitation of brain reward function in rats
    Kenny, PJ
    Boutrel, B
    Gasparini, F
    Koob, GF
    Markou, A
    BEHAVIOURAL PHARMACOLOGY, 2003, 14 : S55 - S56
  • [38] Neuroprotective effect caused by MPEP, an antagonist of metabotropic glutamate receptor mGluR5, on seizures induced by pilocarpine in 21-day-old rats
    Jesse, Cristiano R.
    Savegnago, Lucielli
    Rocha, Joao B. T.
    Nogueira, Cristina W.
    BRAIN RESEARCH, 2008, 1198 : 197 - 203
  • [39] Effect of a metabotropic glutamate receptor 5 antagonist, MPEP, on the nociceptive response induced by intrathecal injection of excitatory aminoacids, substance P, bradykinin or cytokines in mice
    Jesse, Cristiano R.
    Savegnago, Lucielli
    Nogueira, Cristina W.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2008, 90 (04) : 608 - 613
  • [40] Metabotropic Glutamate Receptor 5 and 8 Modulate the Ameliorative Effect of Ultramicronized Palmitoylethanolamide on Cognitive Decline Associated with Neuropathic Pain
    Boccella, Serena
    Marabese, Ida
    Iannotta, Monica
    Belardo, Carmela
    Neugebauer, Volker
    Mazzitelli, Mariacristina
    Pieretti, Gorizio
    Maione, Sabatino
    Palazzo, Enza
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07):
12345